Reporting owner

Farag Kameel D.

Reporting owner CIK 0002093620 · Interim CFO

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsFarag Kameel D.Purchase
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs")Farag Kameel D.Purchase
Nov 1, 2025Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesFarag Kameel D.Stock award
Nov 1, 2025Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesFarag Kameel D.Stock award
Oct 22, 2025Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesFarag Kameel D.Stock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Akari Therapeutics PlcAKTX · company listings
Farag Kameel D.Interim CFO
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P24,7450.4041 *Value: 9,999.4545Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Farag Kameel D.Interim CFO
PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P24,745Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Farag Kameel D.Interim CFO
Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A26,6190.75Value: 19,964.25Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Farag Kameel D.Interim CFO
Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A32,0000.75Value: 24,000Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Farag Kameel D.Interim CFO
Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A6,2770.74Value: 4,644.98Currency not specifiedView ↗